Osteosarcoma in Korean children and adolescents
Osteosarcoma is the most frequent primary bone tumor. Advances in combination chemotherapy and surgical technique have greatly improved the survival of patients with osteosarcoma. In Korea, improvements in osteosarcoma treatment have been made over the past two decades. The 5-year event-free surviva...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Pediatric Society
2015-04-01
|
Series: | Korean Journal of Pediatrics |
Subjects: | |
Online Access: | http://kjp.or.kr/upload/pdf/kjped-58-123.pdf |
_version_ | 1818988542091591680 |
---|---|
author | Jun Ah Lee |
author_facet | Jun Ah Lee |
author_sort | Jun Ah Lee |
collection | DOAJ |
description | Osteosarcoma is the most frequent primary bone tumor. Advances in combination chemotherapy and surgical technique have greatly improved the survival of patients with osteosarcoma. In Korea, improvements in osteosarcoma treatment have been made over the past two decades. The 5-year event-free survival rate of Korean children and adolescents with localized disease is 64.6%, comparable to that of American or European patients. This article provides an overview of current therapies for osteosarcoma in Korea. |
first_indexed | 2024-12-20T19:24:14Z |
format | Article |
id | doaj.art-ac3176ed131e420e9982bdc4b17539ff |
institution | Directory Open Access Journal |
issn | 1738-1061 2092-7258 |
language | English |
last_indexed | 2024-12-20T19:24:14Z |
publishDate | 2015-04-01 |
publisher | Korean Pediatric Society |
record_format | Article |
series | Korean Journal of Pediatrics |
spelling | doaj.art-ac3176ed131e420e9982bdc4b17539ff2022-12-21T19:28:55ZengKorean Pediatric SocietyKorean Journal of Pediatrics1738-10612092-72582015-04-0158412312810.3345/kjp.2015.58.4.12320125550469Osteosarcoma in Korean children and adolescentsJun Ah Lee0Department of Pediatrics, Korea Cancer Center Hospital, Seoul, Korea.Osteosarcoma is the most frequent primary bone tumor. Advances in combination chemotherapy and surgical technique have greatly improved the survival of patients with osteosarcoma. In Korea, improvements in osteosarcoma treatment have been made over the past two decades. The 5-year event-free survival rate of Korean children and adolescents with localized disease is 64.6%, comparable to that of American or European patients. This article provides an overview of current therapies for osteosarcoma in Korea.http://kjp.or.kr/upload/pdf/kjped-58-123.pdfOsteosarcomaKoreaChildAdolescents |
spellingShingle | Jun Ah Lee Osteosarcoma in Korean children and adolescents Korean Journal of Pediatrics Osteosarcoma Korea Child Adolescents |
title | Osteosarcoma in Korean children and adolescents |
title_full | Osteosarcoma in Korean children and adolescents |
title_fullStr | Osteosarcoma in Korean children and adolescents |
title_full_unstemmed | Osteosarcoma in Korean children and adolescents |
title_short | Osteosarcoma in Korean children and adolescents |
title_sort | osteosarcoma in korean children and adolescents |
topic | Osteosarcoma Korea Child Adolescents |
url | http://kjp.or.kr/upload/pdf/kjped-58-123.pdf |
work_keys_str_mv | AT junahlee osteosarcomainkoreanchildrenandadolescents |